Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivo

por Bunch, Brittany L, Morse, Jennifer, Asby, Sarah, Blauvelt, Jamie, Aydin, Ahmet M, Innamarato, Patrick, Hajiran, Ali, Beatty, Matthew, Poch, Michael, Pilon-Thomas, Shari
Publicado 2020

Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors

por Innamarato, Patrick, Morse, Jennifer, Mackay, Amy, Asby, Sarah, Beatty, Matthew, Blauvelt, Jamie, Kidd, Scott, Mullinax, John E., Sarnaik, Amod A., Pilon-Thomas, Shari
Publicado 2021

Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer

por Bazargan, Sarah, Bunch, Brittany, Ojwang‘, Awino Maureiq E., Blauvelt, Jamie, Landin, Annick, Ali, Johannes, Abrahams, Dominique, Cox, Cheryl, Hall, Amy M., Beatty, Matthew S., Poch, Michael, Rejniak, Katarzyna A., Pilon-Thomas, Shari
Publicado 2023

Neoantigen-specific CD4(+) tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients

por Hall, MacLean S., Teer, Jamie K., Yu, Xiaoqing, Branthoover, Holly, Snedal, Sebastian, Rodriguez-Valentin, Madeline, Nagle, Luz, Scott, Ellen, Schachner, Ben, Innamarato, Patrick, Hall, Amy M., Blauvelt, Jamie, Rich, Carolyn J., Richards, Allison D., Ceccarelli, Jake, Langer, TJ, Yoder, Sean J., Beatty, Matthew S., Cox, Cheryl A., Messina, Jane L., Abate-Daga, Daniel, Mule, James J., Mullinax, John E., Sarnaik, Amod A., Pilon-Thomas, Shari
Publicado 2023